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Specific defects in insulin-mediated muscle metabolism in acute uremia.
The mechanisms underlying the abnormal insulin-mediated muscle
glucose metabolism occurring in acute uremia (ARF) have not been
identified. To characterize the defects, insulin dose-response curves for
glucose uptake, glycogen synthesis, glucose oxidation, glycolysis, and
lactate release were measured in incubated rat epitrochlearis muscles.
ARF did not affect insulin sensitivity, but decreased the responsiveness
to insulin of glucose uptake, glycogen synthesis, and glucose oxidation.
Glycogen synthesis was subnormal at all levels of insulin and at the
maximal insulin concentration; it was 54% lower in muscles of ARF
compared to control rats. This inhibition of glycogen synthesis in ARF
could be caused by a 23% decrease in the total activity of muscle
glycogen synthase and the percentage of enzyme in the activated form.
Glycogen phosphorylase activity was unchanged by ARF. ARF also
increased the ratio of muscle lactate release to glucose uptake at
concentrations of insulin from 10 to l0 gU/mi. In the absence and
presence of insulin, muscle protein degradation was increased by ARF.
In individual muscles incubated with insulin, the rate of proteolysis was
correlated with the ratio of lactate release to glucose uptake (r = + 0.82;
P < 0.01). From the insulin dose-response relationships and changes in
enzyme activities, we conclude that ARF increases protein degradation
in muscle and causes abnormal insulin-mediated glucose metabolism.
The abnormalities in glucose metabolism are caused by changes in
post-receptor events.
Défauts specifiques du métabolisme musculaire médié par l'insuline lors
de l'urémie aiguë. Les mdcanismes qui sous-tendent les anomalies du
métabolisme musculaire du glucose médié par l'insuline survenant en
urémie aigue (ARF) n'ont pas été identifies. Afin de caractériser ces
défauts, les courbes dose-réponse a l'insuline pour la captation du
glucose, la synthése de glycogène, l'oxydation du glucose, Ia glycolyse
et la liberation de lactate ont été mesurées dans des muscles
épitrochléens incubés de rat. ARF n'a pas affecté Ia sensibilité a
l'insuline mais a diminué la rCponse insulinique de Ia captation de
glucose, de Ia synthese de glycogene et de l'oxydation do glucose. La
synthése de glycoghne dtait subnormale a tousles niveaux d'insuline, et
a Ia concentration maximale en insuline elle était 54% moindre dans les
muscles de rats ARF par rapport aux contrôles. Cette inhibition de Ia
synthhse de glycogene lors de l'ARF pourrait étre dUe a une baisse de
23% de l'activitd totale de Ia glycogéne-synthétase musculaire et du
pourcentage d'enzyme sous forme activée. L'activité glycoghne-
phosphorylase était inchangée par l'ARF. ARF élevait egalement le
rapport de lactate musculaire libéré a la captation de glucose pour des
concentrations insuliniques de l0-10 U/m1. En l'absence et en prés-
ence d'insuline, la degradation protéique musculaire était accrue par
I'ARF. Dans des muscles individuels incubés avec de l'insuline, Ia
vitesse de Ia proteolyse était corrClée au rapport de la liberation de
lactate a la captation de glucose (r = +0,82; P < 0,01). Des courbes
dose-rhponse a l'insuline et des modifications des activités enzyma-
tiques, nous concluons que l'ARF augmente la degradation protéique
dans le muscle et entraine un métabolisme du glucose médih par
l'insuline anormal. Les anomalies du métabolisme du glucose sont dues
a des modifications des phénomenes en aval des récepteurs.
Acute renal failure (ARF) in experimental animals is associ-
ated with glucose intolerance and increased urea appearance
[1—4]. Insulin-stimulated glucose uptake by perfused hindquar-
ters of ARF rats is clearly subnormal [2, 3] while hepatic
glucose uptake is unaltered [3]. This indicates that the glucose
intolerance of ARF is caused primarily by insulin resistance in
peripheral tissues. Since skeletal muscle has the major role in
glucose disposal [5], it is likely that the insulin resistance of
peripheral tissues resides primarily in muscle. For example,
glycogen synthesis is reduced [2], and it has been suggested that
glycogen phosphorylase activity is abnormal [6] in muscles of
ARF rats. The mechanism underlying the impaired glycogen
synthesis and the possibility that other pathways of insulin-
stimulated glucose metabolism in muscle are abnormal in acute
uremia have not been examined.
The increased rate of urea production in ARF is related to
increased amino acid release from peripheral tissues [1, 2, 4]. In
studying the mechanism of this, we found that the increased net
protein degradation in perfused hindquarters of rats with ARF
was associated with an increase in the proportion of glucose
uptake released as lactate [2]. Because muscle comprises the
major tissue in the hindquarter and because insulin has such an
important role in regulating glucose and protein metabolism in
skeletal muscle, the effects of ARF on insulin-mediated glucose
and protein metabolism in muscle were measured in the present
study. Rates of glucose uptake, glycogen synthesis, glycolysis,
lactate release, glucose oxidation, and net protein degradation
were measured in individual epitrochlearis muscles. Dose-
response relationships between insulin and these processes
were studied to permit a more complete understanding of
insulin resistance in ARF.
Methods
Animals
Male Sprague-Dawley rats weighing 175 to 225 g (Charles
River Breeding Laboratories, Inc., Wilmington, Massachu-
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setts, USA) were housed in a room with a 12-hr light—12-hr
dark cycle. Water and RMH 1000 chow (Agway Country
Foods, Syracuse, New York, USA) containing 14% protein
were permitted ad libitum for at least 3 days before surgery.
Animals were anesthetized with sodium pentobarbital (5 mgIlOO
g body wt, i.p.) and randomly assigned to undergo sham
operation (SO) or bilateral ureteral ligation (ARF). Following
the operation, they were deprived of food and water and placed
in individual wire-bottomed cages to prevent coprophagia.
The serum concentrations of urea nitrogen, creatinine and
glucose, and blood pH were measured in blood obtained from
the aorta of anesthetized rats. Plasma insulin was measured as
described by Freedlander et al [7]. To assess the response to a
glucose load, serum glucose was measured after 1.25 g
glucose/kg body wt was infused intravenously [3].
Materials
D[U-'4Cjglucose and 3H20 were purchased from ICN (Chem-
ical and Radioisotope Division, Irving, California, USA), D[2-
3H]glucose and D[5-3Hjglucose from New England Nuclear
(Boston, Massachusetts, USA) and [1-'4Clpyruvate from
Amersham (Arlington Heights, Illinois, USA). Reagent grade
chemicals were obtained from Fisher Scientific Company (Pitts-
burgh, Pennsylvania, USA) and enzymes and fatty acid and
globulin-free bovine albumin from Sigma Chemical Company
(St. Louis, Missouri, USA). Crystalline porcine insulin was
purchased from Eli Lilly and Company (Indianapolis, Indiana,
USA).
Epitrochlearis muscle incubation
Forty-four to 48 hr after surgery, rats were anesthetized and
their epitrochlearis muscles removed and dissolved immedi-
ately in hot KOH for determination of muscle glycogen content
(see below) or placed in flasks containing 3 ml Krebs-Henseleit
bicarbonate buffer (pH 7.4), 10 m glucose, and 0.2% albumin.
In experiments in which insulin was not added, albumin was
deleted from the media to avoid the possibility of contaminating
insulin-like activity. Flasks were gassed for 3 mm with 95%
02/5% CO2. placed in a 37°C bath and shaken at 60 cycle/mm.
After a 30-mm pre-incubation, the muscles were removed,
blotted, and transferred to flasks containing the same media
plus radiolabelled compounds and various concentrations of
insulin, as indicated. The flasks were regassed and incubated
for a 2-hr experimental period. Each muscle from a rat was
incubated at a different concentration of insulin.
Glucose metabolism
To evaluate glucose metabolism, muscles were incubated in
media that was supplemented with both D[U-14Clglucose (0.02
mCi/mmole) and D[2-3H]glucose (0.1 mCi/mmole) plus different
concentrations of insulin, as indicated. After the experimental
period, the flasks were cooled on ice, and 2 ml of media were
transferred by syringe to another stoppered flask containing 0.5
ml of 50% trichloroacetic acid (V:V) and a suspended center
well containing 0.2 ml phenethylamine. This flask was incu-
bated for an additional hr and the '4C02 trapped in the well was
determined by liquid scintillation counting. Glucose oxidation
was calculated as the rate of '4C02 evolved divided by the
specific radioactivity of D[U-'4C]glucose in the media.
After the removal of 2 ml of media, the muscle was removed
and dissolved immediately in 0.5 ml of 30% potassium hydrox-
ide (W:V) at 100°C. Glycogen was isolated by extraction into
95% ethanol and precipitation at 0°C. The precipitate was
collected by centrifugation and mixed with I ml of 2% LiBr.
After centrifugation, 5 ml of 100% ethanol were added to the
supernatant and the dissolved glycogen was precipitated at 0°C.
Recovery of glycogen with this technique was 91 1%. After
dissolving the precipitate in water, the glycogen concentration
was measured spectrophotometrically [8], and the incorpo-
ration of '4C and 3H into glycogen was measured by liquid
scintillation counting. The rate of glycogen synthesis was
calculated from the incorporation of '4C into glycogen using the
specific radioactivity of D[U-'4C]glucose in the media.
Glucose uptake into muscle was calculated by measuring the
rate of 3H20 formed from D[2-3H]glucose and dividing by the
specific radioactivity of D[2-3]glucose in the media [81. 3H20
was isolated by the method of Ashcroft et a! [9] and in each
experiment, the recovery of 3H20 was measured. This calcula-
tion of glucose uptake depends on the assumption that in
muscle, the tritium label is liberated completely during the
phosphoglucose isomerase reaction [10, 11]. 3H20 release from
D[2-3H]glucose is a valid marker of glucose uptake in incubated
muscles of ARF and SO rats because the amount of 3H
recovered in glycogen and the glycolytic products, lactate,
alanine and pyruvate, did not differ between the two groups. In
individual muscles of ARF (N = 32) or SO (N = 29), <0.5% of
D[2-3H]glucose taken up was incorporated into glycogen. The
glycolytic products in incubation media were isolated by eluting
them from a 4 x 0.5 cm column of Dowex-l (C1)resin (Sigma,
St. Louis, Missouri, USA) with 4 N HC1 [12]. Again, <0.5% of
D[2-3H]glucose uptake was detected in glycolytic products
released into the incubation media. To exclude the possibility
that labelled products were accumulated in muscle, we com-
pared the 3H contained in the acid-soluble fraction of muscle
after correcting for 3H20 in the intracellular space and D[2-
3Hjglucose in the extracellular space. There was no accumula-
tion of 3H in acid-soluble products in either group. Thus,
D[2-3H]glucose can be used to measure glucose uptake in
incubated skeletal muscle. Since the pentose pathway is inac-
tive in skeletal muscle [13], glucose is either incorporated into
glycogen or enters the glycolytic pathway. Therefore, we
calculated the rate of glycolysis as the difference between the
rates of glucose uptake and glycogen synthesis. With this
method, the rates of glycolysis in the two groups of muscles
were indistinguishable statistically. Glycolysis also can be
measured as the rate of 3H20 released from D[5-3H]glucose [8,
14] by assuming that 3H is liberated completely during the triose
phosphate isomerization reaction in muscles of ARF and SO
rats [14]. If this assumption is correct, then rates of glycolysis
measured by this method should be the same as that calculated
from glucose uptake and glycogen synthesis using
D[2-3H]glucose. We assessed the difference between the two
methods in paired experiments using muscles of six ARF and
six SO rats. The two methods yielded the same glycolytic rate
in muscles of ARF rats (22.7 2.2, D[2-3H}glucose method;
21.3 2.6 /Lmole/g/hr, D[5-3H]glucose method). In contrast,
the rate of glycolysis measured with D[5-3H}glucose in muscles
of SO rats was 21.8 3.9% (P < 0.01) lower than that
calculated from the D[2-3H]glucose method. This could explain
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Table 1. Blood chemistries, plasma insulin, and muscle glycogen content of acutely uremic (ARF) and sham-operated (SO) rats
Serum urea nitrogen
mg/dl
Serum creatinine
mg/dl Blood pH
Serum glucose
mg/dl
Plasma insulin
UIml
Muscle glycogen content
p.mole glucoselg muscle
ARF 183 6 4.4 0.2a 7.27 0.03 104 Il 24.3 2.8a 25.68 2.73
SO 24 2 0.3 0.02 7.40 0.02 125 10 13.8 3.3 25.43 2.10
Values are the mean SEM for six to eight rats from each group.
a P < 0.01 compared to values from sham-operated rats.
why we found a lower rate of glycolysis in muscles of SO rats
compared to ARF rats when we used the D[5-3H]glucose
method [15]. Lactate release into the media was measured as
described previously [2, 8].
Pyruvate oxidation was measured during incubation of mus-
cles in glucose-free media containing 10 mU/mi insulin, 0.25 mrvi
or 10mM pyruvate and [l-'4C]pyruvate (1.4 mCi/mmole). The
'4CO2 evolved was trapped in phenethylamine and measured by
liquid scintillation counting as described above. In each exper-
iment, spontaneous conversion of [l-'4Clpyruvate to '4C02 was
measured and subtracted from the rate of 14C02 evolved during
incubation of [l-'4C]pyruvate with muscle.
Glycogen synthase and phosphorylase
In separate experiments, muscles were incubated for 45 mm
in media containing 10 m glucose, with or without 10 mU/mi
insulin. Then the muscles were homogenized in ice-cold 0.5 M
sucrose, 62.5 m glycylglycine, 50 m sodium fluoride, and 10
mM EDTA at pH 7.4, and analyzed immediately to determine
the activity ratios of glycogen synthase (%I) and glycogen
phosphorylase (%a). Glycogen synthase activity was measured
using 6.55 mM uridine diphosphate glucose (UDPG) and trace
amounts of [U-'4C]UDPG (10 mCi/mmole) [16]. The indepen-
dent activity (measured without glucose-6-phosphate) is ex-
pressed as the percentage (%I) of total activity measured in the
presence of 10 mrvi glucose-6-phosphate. Glycogen
phosphorylase activity was measured using 0.2 M glucose-i-
phosphate and trace amounts of [U)4C]glucose-l-phosphate
(300 mCi/mmole) according to the method of Gilboe, Larson,
and Nutall [17]. The active phosphorylase (measured in the
absence of 0.1 M AMP) was expressed as the percentage (%a) of
total activity measured when 0.1 M AMP was added to the
homogenate. Enzyme activities are expressed as imole sub-
strate incorporated into glycogen per g of muscle protein [18].
The glucose-6-phosphate concentration in the supernatant of
muscles homogenized in 1 ml of 5% perchloric acid was
measured by an enzyme assay [19].
Net protein degradation
After CO2 was collected, the acidified incubation media was
assayed for tyrosine using a fluorometric method [20]. Tyrosine
release was used to calculate the rate of net protein degradation
since tyrosine neither accumulates intracellularly nor is synthe-
sized or degraded by skeletal muscle [21, 22]. When 0.5 mi
cycloheximide was added to the media to inhibit protein syn-
thesis so that we could measure total protein degradation,
glycogen synthesis was inhibited by 30 7%. Therefore, the
net rate of tyrosine release (the difference between protein
synthesis and total protein degradation) was measured to assess
the different pathways of glucose metabolism and protein
turnover simultaneously.
Results are presented as mean SEM. An unpaired t test was
used to compare results obtained in muscles of ARF and
sham-operated rats.
Results
As reported previously [1, 2], 48 hr of ARF led to a marked
increase in serum urea nitrogen and creatinine (Table 1).
Although fasting blood glucose was not increased significantly
by ARF, plasma insulin was almost twice that found in SO rats.
Further evidence for abnormal glucose disposal was obtained
by infusing a glucose load of 1.25 g/kg into six rats in each
group. The maximal plasma glucose in ARF rats (429 27
mgldl) was significantly higher than that in SO rats (331 14
mg/dl; P <0.05). The arterial blood pH of ARF rats was the
same as we found in our previous study [2], and was lower than
that of SO rats. The glycogen content of epitrochlearis muscles
from ARF and SO rats after 48 hr of fasting was not different
statistically.
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FIg. 1. The dose-response relationship between msulin and glucose
uptake measured with D[2-3HJglucose. Values at each concentration of
insulin are the mean SEM from muscles of at least six acutely uremic
(ARF) (•) or sham-operated (SO) (0) rats.
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Insulin, /LU/m/
Fig. 2. The dose-response relationship between insulin and glycogen
synthesis measured as the incorporation of D[U-'4C]glucose into gly-
cogen. Values at each concentration of insulin are the mean SEM from
muscles of at least six acutely uremic (ARF) (•) or sham-operated (SO)
(0) rats.
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Fig. 3. The dose-response relationship between insulin and glycolysis
measured as the difference between glucose uptake and glycogen
synthesis. Values at each concentration of insulin are the mean SEM
from muscles of at least six acutely uremic (ARF) (•) or sham-operated
(SO) (0) rats.
Insulin, j.aU/m/
Fig. 4. The dose-response relationship between insulin and lactate
release. Values are the mean SEM from muscles of at least six acutely
uremic (ARF) (•) or sham-operated (SO) (0) rats.
Fig. 5. The dose-response relationship between insulin and the ratio of
glycolysis and lactate release to glucose uptake. Values are mean
SEM of muscles from at least six rats in each group. The ratio of10 glycolysis to glucose uptake (A A) and lactate release to glucose
uptake (0 0) in ARF rats measured in the presence of 10 to l0
jsU/ml insulin was significantly (P < 0.05) higher than they were in
muscles of SO rats (A—A and •, respectively).
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Glucose uptake and metabolism
As shown in Figure 1, ARF decreased the maximal rate of
insulin-stimulated glucose uptake 24%. Half-maximal stimula-
tion of glucose uptake occurred at comparable concentrations
of insulin (66 tU/ml, ARF; 60 U/m1, SO), indicating that
muscles from ARF rats were less responsive to insulin but
maintained a normal insulin sensitivity [23J.
As shown in Figure 2, muscle glycogen synthesis was de-
pressed by ARF at all concentrations of insulin; at the maximal
concentration of insulin studied, muscle glycogen synthesis was
decreased 54% by ARF. The estimated half-maximal rate of
glycogen synthesis in each group of muscles occurred at similar
insulin concentrations (62 U/ml SO; 74 /LU/ml ARF) indicating
that, like glucose uptake, ARF depressed the responsiveness to
insulin without substantially altering insulin sensitivity.
The lower rate of glucose uptake could contribute to the
reduced capacity for insulin-stimulated muscle glycogen syn-
thesis in ARF. If this were the only cause, glycolysis also
should be reduced by ARF because glucose uptake is the
rate-limiting step in glycolysis [241. We found no significant
difference in the rate of glycolysis or lactate release between
muscles of SO and ARF rats at 0 to 10 mU/ml insulin (Figs. 3,
4). However, the ratio of lactate release to glucose uptake was
higher in muscles of ARF rats at all levels of insulin (Fig. 5).
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Table 2. Effects of acute uremia on muscle glycogen synthase and phosphorylase activities and on the intracellular
glucose-6-phosphate concentration
Glycogen synthase Glycogen phosphorylase G-6-P
smole/gI Total a Total
Insulin % UIg protein % UI g protein muscle
ARF
—
+
21.6
25.2
l.9
1.28
1.79 0.088
1.67 O.ll
9.2 0.4
6.2 0.6
45.42 1.93
44.36 2.86
298 25
347 22
SO
—
+
28,1
32.4
2.1
0.7
2.33 0.14
2.20 0.11
7.3 1.3
6.9 0.2
44.35 2.14
42.83 3.54
267 18
349 18
Values are the mean SEM of six muscles in each group. The activity ratios of glycogen synthase (%I) and glycogen phosphorylase (%a) and
the total activities of these enzymes were measured in homogenized muscles immediately after 45 mm of incubation in 10 ms glucose, with or
without 10 mU/mI insulin. In separate experiments, the intracellular concentration of glucose-6-phosphate (G-6-P) was measured.
a p < 0.01 compared to muscles from sham-operated rats.
Similarly, the ratio of glycolysis to glucose uptake was signifi-
cantly increased by ARF. In the absence of insulin, the ratio of
lactate release to glucose uptake was 3, suggesting that there
was net glycogenolysis.
Another cause of depressed glycogen synthesis could be that
the muscle glycogen content in ARF rats exceeded that of SO
rats [25]. However, this was not the case, as shown in Table 1.
To determine the effect of ARF on the enzymes regulating
muscle glycogen, we measured the activities of glycogen syn-
thase and phosphorylase in muscle homogenates. As shown in
Table 2, ARF caused a 23% (P < 0.005) decrease in both the
total activity of glycogen synthase and in the fraction of the
enzyme in the independent form (%I), and these defects per-
sisted during incubation with insulin. In contrast, we found no
significant change attributable to uremia in either the total
activity or activated fraction of muscle glycogen phosphoryl-
ase. Finally, the intracellular concentration of glucose-6-phos-
phate was unchanged by ARF (Table 2). These results suggest
that the lower rate of glycogen synthesis measured in intact
muscles (Fig. 2) was due to inhibition of glycogen synthase
activity rather than to limited availability of substrate or differ-
ences in concentration of the allosteric modifier of glycogen
synthase, glucose-6-phosphate [26].
The maximal rate of insulin-stimulated glucose oxidation was
decreased 30% by ARF, but when the insulin concentration was
lnsuin, UimI
Fig. 7. The dose-response relationship between insulin and the rate of
net protein degradation expressed as nmole tyrosine released per gram
muscle per hr. Values at each concentration of insulin are the mean
SEM from muscles of at least six acutely uremic (ARF) (•) or sham-
operated (SO) (0) rats.
< 500 U/ml, there was no difference in glucose oxidation
between the two groups (Fig. 6). To investigate this decrease in
glucose oxidation at high insulin levels, we measured the effect
of ARF on pyruvate oxidation. There was no evidence for
impairment of pyruvate oxidation since insulin-stimulated CO2
production from 0.25 m pyruvate was 0.35 0.02 smole/g/hr
in muscles of ARF rats and 0.34 0.02 mole/gIhr in muscles
of SO rats. Similarly, when muscles were incubated with
[l-'4C]pyruvate and 10 ms't pyruvate (a concentration which has
been shown to stimulate the activity of pyruvate dehydrogenase
maximally [27]), CO2 production from pyruvate was 6.56 0.40
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Fig. 6. The dose-response relationship between insulin and glucose
oxidation measured as '4C02 releasedfrom D[U-'4C]glucose. Values at
each concentration of insulin are the mean SEM from muscles of at
least six acutely uremic (ARF) (•) or sham-operated (SO) (0) rats.
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Fig. 8. The relationship in individual muscles between the rate of net
protein degradation and the ratio of lactate release to glucose uptake.
The muscles were incubated with insulin concentrations varying from
10 to i0U/ml. Open triangles are values from sham-operated rats and
open circles are values from ARF rats.
p.mole/gfhr in muscles of ARF rats and 6.48 0.49 tmole/g/hr
in muscles of SO rats.
Net protein degradation
As shown in Figure 7, net protein degradation (PD) was
increased in muscles of ARF rats incubated without insulin and
at all levels of insulin, but insulin suppressed net PD in both
groups of muscles to a comparable degree (39% in ARF and
43% in SO). We estimated that it would require 60 U/ml
insulin to reduce the accelerated muscle proteolysis caused by
ARF to the basal rate occurring in SO rats. Our previous studies
have shown that the ARF-induced decrease in muscle protein
synthesis could account for only 25% of the increase in net PD
[2]. Thus, the high net PD seen in Figure 4 primarily reflects an
increased rate of proteolysis.
Previously, we found that the high rate of net PD in the
perfused hindquarters of rats with ARF was positively corre-
lated with the ratio of lactate release to glucose uptake [2]. As
shown in Figure 8, we found a similar relationship in individual
muscles from ARF rats incubated at insulin concentrations
varying from iO—io U/ml (y = 95 x —8; r 0.82; P < 0.001).
The relationship in muscles from SO rats had a similar slope and
intercept (y = 97 x —4), but the correlation (r = 0.55), although
significant (P < 0.001), was lower. When muscles were incu-
bated without insulin, the high ratio of lactate release to glucose
uptake was not correlated with the rate of net PD.
Discussion
In this study, we have identified several abnormalities in
insulin-mediated glucose metabolism and have examined pos-
sible mechanisms underlying the impaired glycogen synthesis
that occurs in muscles of ARF rats. In ARF, muscle glucose
uptake and glycogen synthesis were subnormal in the presence
of physiologic and supraphysiologic concentrations of insulin.
It is unlikely that the decrease in glucose uptake was the sole
factor responsible for the lower rate of glycogen synthesis since
decreased glucose uptake would be expected to reduce
o glycolysis to a comparable degree [24]. In fact, insulin-
stimulated glycolysis was the same in muscles of ARF and SO
rats, indicating that ARF decreases muscle glycogen synthesis
directly. This conclusion was confirmed by our finding that in
muscle homogenates, the total activity of glycogen synthase
was decreased 23% and there was a 40% decrease in the
activated form of the enzyme. Since the glucose-6-phosphate
content of the intact muscle was not reduced by ARF, the lower
rate of glycogen synthesis must have been due to this reduced
glycogen synthase activity rather than to limited availability of
substrate or to differences in allosteric activation of glycogen
synthase by glucose-6-phosphate [261.
In vivo, the decrease in plasma insulin caused by fasting is
associated with suppression of glycogen synthesis and net
25 glycogenolysis [28]. In the present study, fed rats were ran-
domly assigned to ARF and SO groups before surgery and
fasting. Thus, the glycogen content of muscles in the two
groups of rats would be the same before the incubation unless
glycogen phosphorylase activity were stimulated by ARF,
leading to accelerated glycogenolysis. We found that glycogen
phosphorylase activity was not stimulated by ARF (Table 2)
and that the muscle glycogen content of ARF and SO rats was
the same before the incubation (Table 1). Thus, our results
differ from those of Horl and Heidland [6] who reported that
muscle glycogen phosphorylase activity was stimulated by ARF
but that glycogen synthase activity was unaffected.
The results in Figure 4 differ from our previous studies in
which we found that lactate release from the hindquarters of
ARF rats perfused without insulin and with 0.5 mU/mi insulin
was significantly increased. However, in both studies [2; Fig.
5], the ratio of lactate release to glucose uptake was signifi-
cantly increased by ARF. This indicates that ARF caused an
increase in lactate production relative to other pathways of
glucose metabolism in both experimental preparations. The
difference in lactate release by the two preparations could be
due to the following factors: the hindquarter contains tissues
other than muscle; the perfusion media, in contrast to the
incubation media, contained erythrocytes and amino acids and
was delivered to tissues by the microcirculation rather than by
diffusion; glucose flux and the ratio of lactate release to glucose
uptake in the perfused hindquarter is lower than in incubated
muscle [2, 9, 29, 30]. To avoid the confounding influence
contributed by different tissues in the hindquarter, we devel-
oped the methods used in the present study. With these
methods, the pathways of glucose metabolism and protein
turnover were measured simultaneously in individual muscles
and we confirmed that ARF is associated both with a prepon-
derance of lactate production relative to glucose uptake and a
decrease in insulin-stimulated glucose uptake and glycogen
synthesis (Figs. 1, 2). Finally, ARF was associated with a
quantitatively small, but significant, impairment in muscle
glucose oxidation when insulin was present at >500 U/ml (Fig.
6). This defect could not be attributed to impaired flux through
pyruvate dehydrogenase, and its mechanism is unknown.
Previous studies of the insulin resistance of ARF have not
determined whether it was due to a decrease in insulin sensi-
tivity or responsiveness [2, 3, 6]. In muscles of ARF and SO
f
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rats, insulin concentrations that produced half-maximal stimu-
lation of glucose uptake, glycogen synthesis, glycolysis, and
glucose oxidation were similar in each case, indicating a normal
sensitivity to insulin [231. In contrast, the maximal insulin-
stimulated rates of glucose uptake, glycogen synthesis and
glucose oxidation were depressed, indicating a decreased re-
sponsiveness to insulin. Since a maximal increase in insulin-
stimulated glucose transport in skeletal muscle occurs with
occupancy of only 20% of insulin receptors, the finding that
insulin sensitivity was unaltered suggests that acute uremia
caused post-receptor defects in insulin-mediated glucose me-
tabolism [23, 31, 32]. To evaluate insulin resistance further, we
attempted to measure insulin binding to epitrochlearis muscles.
However, there was a high non-specific binding (40 to 50%)that
prohibited us from making a firm conclusion regarding differ-
ences in specific binding of insulin between muscles from ARF
and SO rats. Regardless, the finding of depressed glycogen
synthase activity in muscle of ARF rats identifies a specific
post-receptor defect in insulin-mediated metabolism.
Several reports indicate that uremia causes insulin resistance
by altering post-receptor events. For example, insulin binding
to monocytes obtained from chronically uremic humans with
glucose intolerance was found to be normal, suggesting the
presence of post-receptor defects in glucose metabolism [33].
Besides monocytes, insulin-stimulated glucose uptake and lipid
synthesis from glucose were found to be depressed in
adipocytes isolated from chronically uremic rats. These defects
were present in spite of normal binding of insulin to the fat cells
[34]. The present results indicate that in muscle also, there are
defects in post-receptor events that decrease insulin-mediated
glucose uptake, glycogen synthesis, and, possibly, glucose
oxidation.
The mechanism underlying the accelerated muscle
proteolysis associated with uremia is unknown [35]. It is
controversial whether acidosis increases net PD in muscle [36,
37], but it seems unlikely that our results were caused by
acidosis since the pH of arterial blood in ARF and SO rats was
only slightly different, and the muscles were preincubated for 30
mm and incubated in media at pH 7.4. Intracellular pH in the
two groups of muscles would be similar with this procedure
[38]. Indeed, even when acidosis in ARF rats was prevented by
repeated gavage with bicarbonate, Flugel-Link et al [39] found
that ARF increased muscle PD.
Net PD was increased by ARF in the absence of insulin and
at all concentrations of insulin studied (Fig. 7). The mechanisms
by which insulin inhibits muscle proteolysis and ARF increases
insulin-independent proteolysis are unknown. Consequently,
net PD in ARF cannot be considered resistant to insulin,
especially since the basal rate of net PD was higher in ARF and
there was no apparent difference in the sensitivity of net PD to
insulin [23]. In contrast, glucose metabolism in muscles of ARF
rats was resistant to insulin. This is interesting because it
suggests that ARF affects insulin-mediated muscle glucose
metabolism independently from its effects on protein metabo-
lism. Moreover, because ARF does not alter the basal metab-
olism of glucose but increases insulin-independent proteolysis,
it would appear that glucose and protein metabolism are not
related in muscles of ARF rats. These conclusions extend
beyond our results since it is not understood how insulin
controls muscle glucose or protein metabolism [22]. In fact, we
found that in the presence of insulin the net rate of PD in
individual muscles was correlated with changes in glucose
metabolism, as measured by the ratio of lactate release to
glucose uptake (Fig. 8). We have observed a similar relationship
in other catabolic conditions [8].
Investigation of the mechanisms for the depressed glycogen
synthase activity and other abnormalities in muscle glucose
metabolism that occur in ARF could uncover the basis for
glucose intolerance in uremia. They also could elucidate the
extent to which abnormalities in insulin-stimulated glucose
metabolism change net PD in muscle.
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